Literature DB >> 9237427

Conformational flexibility of serotonin1A receptor ligands from crystallographic data. Updated model of the receptor pharmacophore.

Z Chilmonczyk1, A Szelejewska-Wozniakowska, J Cybulski, M Cybulski, A E Koziol, M Gdaniec.   

Abstract

Preparation and affinity to 5-HT1A and 5-HT2A receptors of new buspirone analogues 7-17 are reported. The compounds possess high to low affinity to 5-HT1A and moderate to low to 5-HT2A receptors. The crystal structures have been determined for compounds 11, 12, 13, and 14. For low affinity ligand (15) of 5-HT1A receptor conformational analysis was performed and compared with similar analyses performed for know high (buspirone 1) and very high (WY-48,723 2) affinity ligands of the receptor. Structure-activity relationship is discussed for the affinity to 5-HT1A receptor. A three-point pharmacophore explaining interactions of buspirone-like molecules with the receptor binding site is proposed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237427     DOI: 10.1002/ardp.19973300507

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  From Homology Models to a Set of Predictive Binding Pockets-a 5-HT1A Receptor Case Study.

Authors:  Dawid Warszycki; Manuel Rueda; Stefan Mordalski; Kurt Kristiansen; Grzegorz Satała; Krzysztof Rataj; Zdzisław Chilmonczyk; Ingebrigt Sylte; Ruben Abagyan; Andrzej J Bojarski
Journal:  J Chem Inf Model       Date:  2017-01-18       Impact factor: 4.956

2.  Synthesis and structure evaluation of new complex butylarylpiperazin-1-yl derivatives.

Authors:  Daniel Szulczyk; Anna Bielenica; Michał A Dobrowolski; Lukasz Dobrzycki; Mariola Krawiecka; Bożena Kuran; Marta Struga
Journal:  Med Chem Res       Date:  2013-09-03       Impact factor: 1.965

3.  A linear combination of pharmacophore hypotheses as a new tool in search of new active compounds--an application for 5-HT1A receptor ligands.

Authors:  Dawid Warszycki; Stefan Mordalski; Kurt Kristiansen; Rafał Kafel; Ingebrigt Sylte; Zdzisław Chilmonczyk; Andrzej J Bojarski
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.